Document 1Q87ryg24odwvZMx3Bao4bq0m

To: Cagen, Stuart Z SCC-CF-SS <stuart.cagen@shell.com>; Clegg, Patsy M SCC- CHSE-PC <patsy.clegg@shell.com>; Tsai, Shan P SHLOIL-SHS <Shan.Tsai@shell.com> From: shan tsai <shantsai@hotmail.com> Cc: Bcc: Received Date: 2004-11-11 06: 10: 07 GMT Subject: RE: draft presentation for your review Stuart, The presentation materials look very good. I have only a few suggestions: 1. Epidemiology Conclusions Pre-1997: the clear risk at exposures is too high. May need to lower to >5ppm. Also change issufficient data to 1-5 ppm 2. Austrilian study - Add "at lower level of benzene exposure" after the first bullet of that slide 3. In the How is the SHS Distinct - what you mean by "the first-hand exposure reports" 4. In the Study #1 - Case Control Study, first bullet, delete "potentially" 5. Overall, too much detailed information in this presentation. Shan Taiwan >From: "Cagen, Stuart Z SCC-CF-SS" <stuart.cagen@shell.com> >To: "Clegg, Patsy M SCC-CHSE-PC" <patsy.clegg@shell.com>,"Tsai, Shan P >SHLOIL-SHS" <Shan.Tsai@shell.com>,<shantsai@hotmail.com> >Subject: draft presentation for your review >Date: Tue, 9 Nov 200414:15:02 -0600 > > > Shanghai Health Study update 16 November 2004.ZIP > > >Stuart Cagen > >Shell Chemical LP >One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916 > >Tel: +1 713241 1407 Fax: +1 713241 3325 Other Tel: +1 8326463987 >Email: stuart.cagen@shell.com >Internet: http://www.shell.com/chemicals > > ShanghaiHealthStudyupdate16November2004.ZIP SH ELL-MCCLU RG-OS4983